Evidence map›Paper›PMID 32522198›Full record

Trial reportJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance2020

Left ventricular functional recovery of infarcted and remote myocardium after ST-segment elevation myocardial infarction (METOCARD-CNIC randomized clinical trial substudy).

Tomaž Podlesnikar, Gonzalo Pizarro, Rodrigo Fernández-Jiménez, Jose M Montero-Cabezas, Nina Greif, Javier Sánchez-González, Chiara Bucciarelli-Ducci, Nina Ajmone Marsan, Zlatko Fras, Jeroen J Bax and 3 more

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01311700 (Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The ME"Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion"), which is not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01311700 phase4completednot on this map

Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The ME"Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion" (METOCARD-CNIC): A Randomized, Controlled Parallel-group, Observer-blinded Clinical Trial of Early Pre-reperfusion Metoprolol Administration in ST-segment Elevation Myocardial infarctionTOCARD-CNIC Trial.

TypeinterventionalSponsorFundación Centro Nacional de Investigaciones Cardiovasculares Carlos IIIRan2010 to 2017Enrolled221ConditionsMyocardial InfarctionArmsInjectable (i.v.) metoprolol tartrate (up to 15 mg).
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Anterior STEMI associated with decreased strain in remote cardiac myocardium.The international journal of cardiovascular imaging · 2022
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. 2021-2022 state of our JCMR.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. 2021 - State of our JCMR.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tomaž PodlesnikarDepartment of Cardiology, Heart Lung Center, Leiden University Medical Center, Albinusdreef 2, 2333, ZA, Leiden, The Netherlands.
Gonzalo PizarroCentro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Rodrigo Fernández-JiménezCentro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Jose M Montero-CabezasDepartment of Cardiology, Heart Lung Center, Leiden University Medical Center, Albinusdreef 2, 2333, ZA, Leiden, The Netherlands.
Nina GreifFaculty of Medicine University of Maribor, Maribor, Slovenia.
Javier Sánchez-GonzálezPhilips Healthcare, Madrid, Spain.
Chiara Bucciarelli-DucciBristol Heart Institute, Bristol NIHR Cardiovascular Research Centre, University of Bristol and University Hospitals Bristol NHS Trust, Bristol, UK.
Nina Ajmone MarsanDepartment of Cardiology, Heart Lung Center, Leiden University Medical Center, Albinusdreef 2, 2333, ZA, Leiden, The Netherlands.
Zlatko FrasInternal Medicine Clinic, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Jeroen J BaxDepartment of Cardiology, Heart Lung Center, Leiden University Medical Center, Albinusdreef 2, 2333, ZA, Leiden, The Netherlands.
Valentin FusterCentro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Borja IbáñezCentro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Victoria DelgadoDepartment of Cardiology, Heart Lung Center, Leiden University Medical Center, Albinusdreef 2, 2333, ZA, Leiden, The Netherlands. v.delgado@lumc.nl.

Funding

Department of Health
6 · The paper itself

Abstract

backgroundWe aimed to evaluate the effect of early intravenous metoprolol treatment, microvascular obstruction (MVO), intramyocardial hemorrhage (IMH) and adverse left ventricular (LV) remodeling on the evolution of infarct and remote zone circumferential strain after acute anterior ST-segment elevation myocardial infarction (STEMI) with feature-tracking cardiovascular magnetic resonance (CMR).

methodsA total of 191 patients with acute anterior STEMI enrolled in the METOCARD-CNIC randomized clinical trial were evaluated. LV infarct zone and remote zone circumferential strain were measured with feature-tracking CMR at 1 week and 6 months after STEMI.

resultsIn the overall population, the infarct zone circumferential strain significantly improved from 1 week to 6 months after STEMI (- 8.6 ± 9.0% to - 14.5 ± 8.0%; P < 0.001), while no changes in the remote zone strain were observed (- 19.5 ± 5.9% to - 19.2 ± 3.9%; P = 0.466). Patients who received early intravenous metoprolol had significantly more preserved infarct zone circumferential strain compared to the controls at 1 week (P = 0.038) and at 6 months (P = 0.033) after STEMI, while no differences in remote zone strain were observed. The infarct zone circumferential strain was significantly impaired in patients with MVO and IMH compared to those without (P < 0.001 at 1 week and 6 months), however it improved between both time points regardless of the presence of MVO or IMH (P < 0.001). In patients who developed adverse LV remodeling (defined as ≥ 20% increase in LV end-diastolic volume) remote zone circumferential strain worsened between 1 week and 6 months after STEMI (P = 0.036), while in the absence of adverse LV remodeling no significant changes in remote zone strain were observed.

conclusionsRegional LV circumferential strain with feature-tracking CMR allowed comprehensive evaluation of the sequelae of an acute STEMI treated with primary percutaneous coronary intervention and demonstrated long-lasting cardioprotective effects of early intravenous metoprolol.

trial registrationClinicalTrials.gov, NCT01311700. Registered 8 March 2011 - Retrospectively registered.

Indexed as

Percutaneous Coronary InterventionAdministration, IntravenousAdrenergic beta-1 Receptor AntagonistsAgedAnterior Wall Myocardial InfarctionFemaleHumansMagnetic Resonance Imaging, CineMaleMetoprololMiddle AgedMyocardiumRecovery of FunctionST Elevation Myocardial InfarctionTime FactorsTreatment OutcomeAdrenergic beta-1 Receptor AntagonistsMetoprololFeature-tracking cardiovascular magnetic resonanceIntramyocardial hemorrhageIntravenous metoprololLeft ventricular remodelingMicrovascular obstructionST-segment elevation myocardial infarction

Identifiers

PMID32522198
PMCPMC7288440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.